Zanosar

Zanosar (Streptozocin) is an intravenous chemotherapy medication used primarily for pancreatic cancer treatment. This alkylating agent targets specific cancer cells while minimizing impact on healthy tissue. Always consult a healthcare provider for personalized guidance.

Zanosar is prescribed for treating pancreatic islet cell carcinoma, a rare form of pancreatic cancer. It may also be used in research settings for other conditions. Patients often ask, 'what is Zanosar used for' when discussing treatment options with their doctor. This medication works by interfering with cancer cell growth.

Common effects of Zanosar include nausea, vomiting, and fatigue during treatment. Some patients report changes in kidney function or blood cell counts, which are typically monitored by healthcare providers. These effects vary based on individual health and dosage.

Zanosar should only be administered under medical supervision due to its potent effects. Patients with kidney or liver issues may need adjusted monitoring. Always disclose full medical history to your healthcare provider before starting treatment.

Zanosar may interact with medications that affect kidney function or blood cell production. Alcohol and certain vaccines should be avoided during treatment. Always inform your doctor about all prescriptions, over-the-counter drugs, and supplements you are taking.